Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of AgomAb Therapeutics is 0.2% (very low). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
19 mandates
19
active directors
BOND Colin MichaelDirectorJohn HaurumDirectorDavid EpsteinDirector+16 in history
All directors & mandates Publicationslatest 17-04-2026
101
publications in the State GazetteArticles of association amendedAll publications & acts Network & structure
21
connected companiesSee network & structure
Connections
21 connected companiesParent · 455 subsidiaries · 9 locations
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2017 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.2%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Overige technische testen en toetsen71209Overige technische testen en toetsen71209Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Speur- en ontwikkelingswerk op biotechnologisch gebied72101Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Speur- en ontwikkelingswerk op biotechnologisch gebied72110Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
| Legal nameNL | AgomAb Therapeutics |
Registered office
Posthoflei 1 bus 6
2600 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.